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Secretory immunoglobulin A (SIgA) represents
a first line of defense against mucosal patho-
gens by limiting their entrance. By using dif-
ferent strains of Salmonella typhimurium that
target the two mechanisms of bacterial entry
(microfold cell [M cell]- or dendritic cell-medi-
ated), we demonstrated here that the distribu-
tion of bacteria after oral infection directed the
type of induced immune response. M cell-pen-
etrating invasive, but not noninvasive, S. typhi-
murium was found in large numbers in Peyer’s
patches (PPs), leading to the activation of im-
mune cells and the release of fecal IgA. In con-
trast, both strains of bacteria were equally ca-
pable of reaching the mesenteric lymph node
and the spleen and inducing IgG responses.
These data suggest that PPs are absolutely
required for the initiation of an IgA response to
Salmonella, whereas they are dispensable for
a systemic response. This compartmentaliza-
tion could allow the fast generation of both
mucosal and systemic acquired immunity to
pathogens.
INTRODUCTION
The sites and cells involved in the induction of an immune
response to oral invasive pathogens like Salmonella typhi-
murium are still a matter of debate (Mastroeni and
Sheppard, 2004; Mastroeni et al., 2000). Salmonella typhi-
murium has the ability to invade host cells via the expres-
sion of a type-three secretion system (TTSS) encoded
within the Salmonella pathogenicity island I (SPI-1) that
injects virulence factors into target cells and drives cyto-
skeleton rearrangements and phagocytosis (Galan,
2001). Salmonella is also equipped with a flagellar motor
that confers high motility (DeRosier, 1998). These features
allow Salmonella to efficiently invade microfold cells (M
cells) (Baumler et al., 1997; Jones et al., 1994; Marchetti
et al., 2004; Penheiter et al., 1997) that are interspersed
in the follicle-associated epithelium (FAE) that lines the
Peyer’s patches (PPs) and isolated lymphoid follicles. In
addition, we have recently described that SalmonellaImcan enter the host also through dendritic cells (DCs) that
can extend dendrites from the lamina propria (LP) across
the mucosal epithelium (Rescigno et al., 2001b). Because
DCs are phagocytic cells, they can take up through this
route both invasive and noninvasive bacteria. Expression
of the chemokine receptor CX3CR1 by the DCs (Niess
et al., 2005) and Toll-like receptor (TLR) signaling by epi-
thelial cells (Chieppa et al., 2006) are required for the ex-
tension of the DC processes. Entry via these two distinct
routes could lead to a different distribution of Salmonella.
In fact, Salmonella entry via M cells delivers bacteria di-
rectly into the subepithelial dome of PPs, whereas capture
of Salmonella by intraepithelial DCs can deliver the Salmo-
nella to the LP and the mesenteric lymph nodes (MLNs).
Invasiveness of Salmonella could influence the immuno-
logical outcome, as suggested by Vazquez-Torres et al.,
who showed that noninvasive Salmonella was unable to
induce intestinal immunoglobulin A (IgA) (Vazquez-Torres
et al., 1999).
In its secreted form, secretory IgA (SIgA) consists of two
monomeric IgAs linked by the J chain and the secretory
component, which is derived by the proteolytic cleavage
of the polymeric Ig receptor (pIgR) that ensures transcyto-
sis of the dimeric IgA across epithelial cells (Mostov,
1994). Intestinal IgAs play amajor role in protecting muco-
sal surfaces against colonization and invasion by patho-
genic microorganisms (Brandtzaeg, 2003; Kraehenbuhl
and Neutra, 1992; Mestecky and McGhee, 1987) but also
in limiting commensal bacteria to the intestinal lumen
(Macpherson and Harris, 2004; Macpherson and Uhr,
2004). Mice bearing tumors secreting into the gastrointes-
tinal tract a Salmonella-specific monoclonal IgAs are pro-
tected against oral challenge with Salmonella (Michetti
et al., 1992), confirming an important function of SIgA in
anti-Salmonella immunity.
The site where IgA class switching takes place is still
controversial. It was first described that PPs are the major
site for the generation of IgA+ B cells (Cebra and Shroff,
1994). However, mice lacking or having poorly developed
PPs (Neumann et al., 1996; Vajdy et al., 1995) have a large
amount of IgA, suggesting that IgA class-switch recombi-
nation (CSR) can also occur at sites other than the PP. This
hypothesis is supported by data showing that IgA CSR
can take place directly in the LP (Fagarasan et al., 2001;
Xu et al., 2007). These discrepancies could be due to
the different nature of the antigens and/or their route of en-
try into the host. Two types of B cells have been described
in the mouse. B1 cells represent a more ancient type of Bmunity 27, 975–984, December 2007 ª2007 Elsevier Inc. 975
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Salmonella-Induced Immune Responselymphocyte that is dominant in the peritoneal and pleural
cavities (Hayakawa and Hardy, 1988). IgAs derived from
this cell type have broader specificity and low affinity. B1
cells are found within the LP and are likely to be activated
in a T cell-independent fashion (Macpherson et al., 2000).
Similarly, in humans, CSR to IgA can occur in a CD40-
independent manner by DCs in the presence of interleu-
kin-10 (IL-10) or transforming growth factor-b (TGF-b) via
a mechanism that is mediated by the tumor necrosis fac-
tor family members B lymphocyte stimulator (BLyS) and
a proliferation-inducing ligand (APRIL) (Litinskiy et al.,
2002). B2 cells are generated in the bone marrow and
are found in the PP, where they require antigenic stimula-
tion and the formation of germinal centers (GCs) for their
development and switching to IgA (Cebra et al., 1991;
Cebra and Shroff, 1994). Therefore, it is likely that depend-
ing on the localization of the antigen (PP versus the LP),
one of the two responses are initiated, leading to the pro-
duction of either antigen-specific or polyreactive IgAs. In
this study, we have analyzed whether the ability of Salmo-
nella to invade M cells or to enter via the DC-mediated
mechanism could affect the type of induced immune re-
sponse. By using two different strains of Salmonella, one
that is invasive and another one that is deficient in the
invA gene and is unable to make a productive SPI-1
TTSS, we showed that localization of Salmonella within
the host directed the type of induced immune response.
RESULTS
Type-Three Secretion System Is Required
for Salmonella Localization in Peyer’s Patches
Because TTSS encoded within the SPI-1 is needed by
S. typhimurium to enter M cells (Baumler et al., 1997;
Jones et al., 1994; Marchetti et al., 2004; Penheiter
et al., 1997), we analyzed whether it is required for PP col-
onization. We used a mutant of SL1344 strain of Salmo-
nella that is deficient in the invA gene (InvA) and is defec-
tive in the expression of the SPI-1 TTSS (Everest et al.,
1999). We compared the ability of wild-type (WT) (InvA+)
and InvA bacteria to colonize secondary lymphoid or-
gans after oral administration. Six days after infection
with replicating bacteria, there was a significant difference
in S. typhimurium colonization of PPs between mice in-
fected with InvA+ and InvA bacteria, whereas both
strains were equally present in MLNs and spleens (SPs)
(Figure 1A). The bacteria colonization correlated with
results from a gross examination of lymphoid organs;
PPs were highly enlarged only in mice fed with InvA+
S. typhimurium, whereas MLNs and spleens were equally
enlarged in mice infected with both strains (data not
shown). Consistently, at earlier time points (18 hr after
infection), we were able to detect InvA+, but not InvA,
S. typhimurium in PPs by immunohistochemistry (Fig-
ure 1B, bottom row). In contrast, the intestinal villi stained
positive for Salmonella after both InvA+ and InvA infec-
tions as compared to untreated samples (Figure 1B, top
row), probably because of the ability of DCs to take up976 Immunity 27, 975–984, December 2007 ª2007 Elsevier IncnoninvasiveS. typhimurium. Indeed,mice lacking the che-
mokine receptor CX3CR1 are unable to extend DC pro-
cesses, and Salmonella is not found in the lamina propria
(Niess et al., 2005). We ruled out the possibility that the
InvA strain was more sensitive to the acidic stomach
environment and reached the intestine in limited numbers.
Thus, we fed the mice with metabolically defective non-
replicating bacteria (aroA) and recovered the feces up
to 6 hr after infection for bacterial counts. A similar amount
of live bacteria was recovered from feces of mice treated
with invasive (aroA) or noninvasive (aroAinvA) Salmonella
(Figure 1C). Therefore, both strains have a similar ability
to survive in the gastrointestinal tract. These data show
that S. typhimurium needs a functional TTSS to enter PPs,
whereas it can reach other secondary lymphoid tissues
even in the absence of TTSS.
In Vivo Development of Ig Responses
against S. typhimurium
It has been described that PPs are the major site for IgA
CSR. Because TTSS seemed to be indispensable to reach
PPs (Figure 1A), we analyzed whether the different locali-
zation of invasive and noninvasive Salmonella could affect
the type of induced immune response. We immunized
mice with nonreplicating invasive (aroA) and noninvasive
(aroAinvA) S. typhimurium and we followed the develop-
ment of the immune response in terms of anti-Salmonella
IgG and IgA titers in blood and feces, respectively. Both
strains were able to induce secretion of serum IgG (Fig-
ure 2A), with the same kinetic, whereas fecal IgA was se-
creted only after aroA infection (Figure 2B). We also mea-
sured the secretion of anti-Salmonella IgM in the feces,
but we could not detect it after vaccination (data not
shown). We then examined whether we could evaluate
the CSR to IgA by measuring a postswitch transcripts in
PPs of mice that were either left untreated or fed with inva-
sive or noninvasive S. typhimurium. We found only a slight
increase in the postswitch transcripts when mice were
treated with invasive bacteria (Figure S1A available on-
line). This small increase was not surprising because we
showed that IgA+ cells could be detected in both un-
treated (Figure 2C, left column) and treated mice, even
though there was a greater number of cells stained posi-
tive for IgA in PPs of mice fed with invasive (Figure 2C,
middle column) thanwith noninvasive S. typhimurium (Fig-
ure 2C, right column). We also found a higher polymeric Ig
receptor (pIgR) expression after infection with invasive
bacteria in small intestine isolated epithelial cells (Fig-
ure S1B). This, together with the increased amount of
IgA+ cells in the PP, could be responsible for the aug-
mented secretion of Salmonella-specific IgAs in the feces
of invasive S. typhimurium-infected mice. In agreement,
we also found that Salmonella-specific IgA antibody-se-
creting cells (SL-specific IgA ASCs) were generated only
after infection with invasive S. typhimurium. These cells
appeared 2 weeks after the treatment and peaked after
4 weeks (Figure 2D). No SL-specific IgA ASCs were found
in PPs of mice that were left untreated or received nonin-
vasive S. typhimurium (Figure 2D). Altogether, these data.
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Salmonella-Induced Immune ResponseFigure 1. S. typhimurium Colonization of Peyer’s Patches after Oral Infection Depends on Active Type-Three Secretion System
(A) C57BL/6 mice (n = 12/group) were left untreated (NT) or fed with 107 CFUs of invasive (InvA+) or 108 CFUs of noninvasive (InvA) replicating
S. typhimurium. Six days after infection, mice were sacrificed. Culturable bacteria in Peyer’s patches (PP, left), mesenteric lymph nodes (MLN, mid-
dle), and spleens (SP, right) are shown. No bacteria were found in untreated mice. Data are presented as mean ± standard error (SE) and are pooled
from five experiments. * indicates p < 0.05.
(B) C57BL/6 mice were left untreated (left column) or fed with 0.5 3 109 CFUs of invasive (middle column) or 109 CFUs of noninvasive (right column)
S. typhimurium. After 18 hr, PPs were collected and embedded in OCT compound. Cryosections were stained with Salmonella sp. antiserum (rabbit),
HRP-conjugated anti-rabbit and developed with DAB reagent. Sections were counterstained with hematoxilin. The top row shows intestininal ileal villi
staining at 203magnification, the bottom row shows Peyer’s patches staining at 403magnification, and the inset shows a 53magnification of one
representative section.
(C) Invasive and noninvasive S. typhimurium have the same capability to survive in the mouse gastrointestinal tract. C57BL/6 mice (n = 4/group) were
fed with 109 CFUs of recombinant pDsRed S. typhimurium (aroA, invasive; aroAinvA, noninvasive). Total feces were collected from single mice every
2 hr, and serial dilutions were plated onto TB-agar plates supplemented with IPTG for the evaluation of S. typhimurium viability. Data are presented as
mean ± SE (millions of recovered bacteria) and are pooled from two experiments.suggest that only invasive S. typhimurium that enters the
PP can induce specific IgA CSR.
Impaired Fecal IgA Is Not Dependent on Defects
Related to the Lack of SPI-1
We asked whether such different response could be due
to the lack of the SPI-1 operon that by itself could affect
the overall immune response beyond only affecting the
route of infection. To test this possibility, we undertook
two strategies. In the first, we used the BCR-HEL VDJ ki
mice, in which B cells express a B cell receptor (BCR)
that is specific for hen egg lysozyme (HEL) (Figure S2A)
but can still undergo CSR. We expressed HEL on the
surface of invasive and noninvasive S. typhimurium as a
fusion protein with the Pseudomonas Aeruginosa Opr-I
protein (Cornelis et al., 1996) (Figures S2B and S2C) and
evaluated the ability of B cells to undergo CSR in vitro inresponse to bacteria that expressed or did not express
HEL. At day 0 of culture, freshly isolated PP cells were
composed primarily of IgM+ cells (>90%). Seven days
after exposure to both invasive and noninvasive HEL-
expressing S. typhimurium, but not control strains, 40%–
50% of cells expressed surface IgA (Figure 3A). In addi-
tion, when we coincubated total cells from the PP, MLN,
and SP of BCR-HEL VDJ ki mice with HEL-surface-
expressing Salmonellae, we found that, contrary to what
was observed in vivo, both strains were equally capable
to induce HEL-specific IgG and IgA secretion in vitro (Fig-
ures 3B and 3C). In the second strategy, we engineered
noninvasive Salmonella to express the invasin gene of
Yersinia enterocolitica (aroAinvApInv). The invasin protein
of Yersinia binds b1 integrins and can selectively target
bacteria access to PPs (Grutzkau et al., 1990; Isberg
andLeong, 1990).Ascompared tononinvasiveSalmonella,Immunity 27, 975–984, December 2007 ª2007 Elsevier Inc. 977
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Salmonella-Induced Immune ResponseFigure 2. Invasive S. typhimurium Induces Mucosal IgA Response
(A and B) C57BL/6 mice (n = 6/group) were fed with 109 CFUs of invasive (aroA, black bars) or noninvasive attenuated S. typhimurium (aroAinvA, gray
bars) three times on alternate days. Serum and fecal samples were collected before the infection and weekly for 6 weeks after the infection. The pres-
ence of S. typhimurium specific IgG in serum (A) and IgA in feces (B) was evaluated by ELISA. Data are presented as mean ± SE of OD450 and are
representative of six independent experiments. In (B) * indicates that starting from week 2, the content of Salmonella-specific IgA in samples from
mice that received the two vaccination regimens is statistically significantly different.
(C) C57BL/6 mice were left untreated (left column) or fed with 109 CFUs of aroA (middle column) or aroAinvA (right column) S. typhimurium three times
on alternate days. Seven days after the last infection, mice were sacrificed, and PPs were collected and embedded in OCT compound. Cryosections
were stained with anti-mouse IgA (rabbit), HRP-conjugated anti-rabbit and developed with DAB reagent. Sections were counterstained with hema-
toxilin. The top row shows 103magnification; the bottom row shows 203magnification of one representative section (insets represent digital zooms
of selected IgA-enriched areas).
(D) C57BL/6mice (n = 3/group) were left untreated (NT) or fed with 109 CFUs of aroA or aroAinvA S. typhimurium. PPs were collected 2, 4, and 6weeks
after the infection. The presence of Salmonella-specific IgA antibody-secreting cells (ASC) was evaluated by ELIspot.aroAinvApInv displayed a 2-fold increased penetration in
epithelial cells (Figure S3A). This correlated with a propor-
tional increase in IgA release in the feces that was signifi-
cantly higher than in untreated animals (Figure S3B; p =
0.01). Together, these data suggest that the absence of
IgAdetectionafter infectionwithanoninvasivestrainofSal-
monella is not due to the SPI-1 operon and reacquisition of
invasive properties restores IgA release.
Spleens are Dispensable for IgG Induction
PP colonization seems not to be necessary for the stimu-
lation of a systemic response because both strains were978 Immunity 27, 975–984, December 2007 ª2007 Elsevier Inc.able to induce anti-Salmonella IgG in the serum. Because
Salmonella could localize to the spleen regardless of the
expression of the SPI-1 TTSS, we wondered whether
anti-Salmonella IgG responses were induced at this site.
Interestingly, spleen also seemed to be dispensable to
mount an IgG responsebecausewe found similar amounts
of anti-Salmonella IgG in normal or splenectomized mice
after vaccination (Figure S4A). S. typhimurium could be
found only in the MLN and not other nondraining lymph
nodes (Figure S4B), suggesting that in the absence of the
spleen, there is no major spreading of bacteria to other
peripheral lymphoid tissues. Further, we could detect g1
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Salmonella-Induced Immune ResponseFigure 3. Noninvasive S. typhimurium Promotes IgA Production In Vitro
(A) The percentage of IgM- and IgA-positive cells in freshly isolated PP samples was evaluated by flowcytometry (left, day 0). The percentage of total
IgA-positive cells 7 days after infection with invasive or noninvasive HEL-expressing bacteria was evaluated by flow cytometry (right, day 7).
(B and C) Total cells (106) from the PP, MLN, or SP of BCR-HEL VDJ ki mice were left untreated (NT, white bars) or cocultured for 4 hr with aroA (black
and dark gray bars) or aroAinvA (medium and light gray bars)S. typhimurium that expressed or did not express HEL. Seven days after the infection, the
presence of HEL-specific IgG (B) or IgA (C) in supernatants was evaluated by ELISA. Data are presented as mean of OD450 ± SE and are represen-
tative of three experiments.circular transcripts that are indicative of ongoing IgG1
class-switch recombination in the MLNs and to a lesser
extent also in the spleens of mice infected with both inva-
sive and noninvasiveSalmonella (Figure S4C). Thus, a sys-
temic anti-Salmonella response can be initiated in MLNs.
Only Invasive S. typhimurium Activates
the Immune System in Peyer’s Patches
Because only invasive S. typhimurium elicited the secre-
tion of fecal IgAs, we investigated whether the presence
of invasive S. typhimurium in PPs correlated with the acti-
vation of the immune system at this site. S. typhimurium
infection induces the secretion of proinflammatory cyto-
kines, and we measured the amounts of IL-1b in infected
mice. InvA+ S. typhimurium-infected mice exhibited a sta-
tistically significantly higher IL-1b production in the PP
when compared with mice fed with InvA bacteria or left
untreated (Figure 4A). In contrast, in the MLN and spleen,
the production of IL-1bwas increased in response to both
InvA+ and InvA infection, confirming that both bacteria
can reach these sites. Because DCs need to be activated
in order to mount an adaptive immune response, we ana-
lyzed the expression of DC-activation markers (major his-
tocompatibility complex [MHC] class I and CD86) on PP
CD11c+ cells. Only InvA+ S. typhimurium-infected mice
upregulated the expression of MHC class I, whereas
mice infected with InvA S. typhimurium had MHC class
I expression similar to that of untreated mice (Figure 4B).
No changes in CD86 expression were found in either con-
dition. In contrast, CD86 expression on MLN (Figure 4C)
and splenic (Figure 4D) DCs was increased after both
treatments, whereas MHC class I seemed to be upregu-Imlated by both bacterial treatments only on splenic DCs.
Finally, we tested whether PP CD19+ B cells were also
activated upon invasive S. typhimurium infection. Similar
to PP DC activation, only invasive S. typhimurium-infected
mice showed upregulation of MHC class II and CD86
expression on PP B cells (Figure 4E). Surprisingly, only in-
vasive S. typhimurium induced upregulation of CD86 on
MLN (Figure 4F) and splenic (Figure 4G) B cells, whereas
CD40 expression was not affected at all by bacteria treat-
ment. Whether this indicates that B cells activated in the
PP migrate to these sites remains to be elucidated. The
downregulation of MHC II on MLN CD19+ cells after
invasive S. typhimurium treatment remains unclear (Fig-
ure 4F). Altogether, these data suggest that the entrance
of S. typhimurium in PPs correlates with the development
of an inflammatory reaction and the activation of immune
cells, including dendritic cells and B cells.
Fecal IgA Protects Mice against Challenge
of Pathogenic S. typhimurium
Secretory IgA was shown to play a major role in immune
exclusion by impeding pathogens and also commensals
to penetrate the epithelium, thus participating in the pres-
ervation of the homeostasis of the gut. We found high
amounts of fecal IgA specific for S. typhimurium only in
mice vaccinated with invasive bacteria (Figure 2B). There-
fore, we compared resistance to a lethal dose of patho-
genic S. typhimurium (SL1344) given via the oral route to
mice immunized with invasive or noninvasive bacteria
(Figure 5). Mice that were pretreatedwith invasive bacteria
were significantly more resistant to infection with very high
dose of virulent Salmonella (107 colony-forming unitsmunity 27, 975–984, December 2007 ª2007 Elsevier Inc. 979
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Salmonella-Induced Immune ResponseFigure 4. Invasive S. typhimurium Activates the Immune System in Peyer’s Patches
(A–D) C57BL/6 mice (n = 4–5/group) were left untreated (NT, white) or fed with 107 CFUs of InvA+ (black) or 108 CFUs of InvA (gray) replicating
S. typhimurium. Six days after infection, mice were sacrificed, and PPs, MLNs, and SPs were collected. IL-1b in total cell lysates was measured
by ELISA (A). Each dot represents an individual mouse. Lines show mean values. Increment in MHC class I and CD86 expression on CD11c+ gated
cells in the PP (B), MLN (C), and SP (D) was evaluated in treated versus untreated mice.
(E–G) C57BL/6 mice (n = 4/group) were left untreated (NT, white) or fed with 109 CFUs of aroA (black) or aroAinvA (gray) attenuated S. typhimurium
three times on alternate days. Four days after the last infection, mice were sacrificed, and PPs, MLNs, and SPs were collected. Increment in MHC
class II, CD86 and CD40 expression on CD19+ gated cells in the PP (E), MLN (F), and SP (G) was evaluated in treated versus untreated mice.
(B–G) Data are presented as mean ± SE of the ratio MFI (treated)/MFI (untreated). * indicates p < 0.05 when compared to other samples of the same
group.[CFUs]), and 60% of mice survived the lethal dose. Death
of mice that were immunized with noninvasive bacteria,
which lacked intestinal IgA specific for Salmonella, was
only delayed when compared to that of control mice,
probably due to the systemic response elicited during
the vaccination. These data suggest that anti-Salmonella
IgAs can protect against a lethal dose of virulent S. typhi-
murium.
DISCUSSION
Secretory IgAs represent a first line of defense againstmu-
cosal pathogens by limiting the entrance of bacteria, a pro-
cess named ‘‘immune exclusion’’ (Brandtzaeg, 2003;
Kraehenbuhl and Neutra, 1992; Mestecky and McGhee,
1987). By using different strains of Salmonella typhimu-
rium that can or cannot invade M cells, we demonstrated
here that the distribution of bacteria after oral administra-
tion directed the type of induced immune response, the
production of SIgAs, and subsequent protective immu-
nity. Invasive S. typhimurium that can cross M cells was
found in large numbers in PPs, and this correlated with
the enlargement of the PP, the activation of immune cells,980 Immunity 27, 975–984, December 2007 ª2007 Elsevier Incand the release of SIgAs in the feces. In contrast, minimal
noninvasive S. typhimurium was detected in the PP, they
did not induce immune cell activation in this site, and
they did not lead to SIgA release. Consistent with the find-
ing that PPDCs have the unique ability to drive IgA-secret-
ing B cells (Mora et al., 2006; Sato et al., 2003) and that IgA
CSR takes place primarily in the PP and not in the MLN or
isolated lymphoid follicles (Bergqvist et al., 2006), our data
indicate that PPs are absolutely required for the induction
of Salmonella-specific SIgA release. We can exclude that
noninvasive bacteria were unable to induce IgA CSR for
two reasons: (1) In vitro interaction of noninvasive S. typhi-
murium with PP cells resulted in IgA production, and (2)
the engineering of noninvasive Salmonella with invasin
gene of Yersinia, which targets bacteria to the PP (Grutz-
kau et al., 1990; Isberg and Leong, 1990), resulted in IgA
release in vivo.
S. typhimurium could be detected in the LP, and this is
consistent with recent reports showing that DC extensions
are involved in the uptake of luminal bacteria regardless of
their invasiveness (Chieppa et al., 2006; Niess et al., 2005;
Rescigno et al., 2001a) and that in mice deficient for the
chemokine receptor CX3CR1, lacking DC protrusions,.
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faces (Niess et al., 2005). Because noninvasive S. typhi-
murium could enter the host and was found in the LP,
MLN, and the spleen but still no anti-Salmonella-specific
SIgAs could be detected in the feces, it is likely that these
sites are not required for the production of Salmonella-
specific SIgAs. This is the first evidence of the compart-
mentalization of the IgA response in mice that are not im-
munocompromised, have regularly organized lymphoid
tissue, and possess a normal intestinal flora.
Our data support the notion that bacteria equipped with
a functional TTSS (in our case invasive S. typhimurium) in-
duce their own phagocytosis by PP M cells. Once they
penetrate in PPs, they promote the activation of B2 cells,
the B cell population present in this site. In PP germinal
centers, B2 cells undergo CSR and somatic hypermuta-
tion (SHM); these events lead to the generation of anti-
gen-specific B cells carrying high-affinity BCR. These cells
can then migrate into effector sites (LP) and differentiate
into antibody-secreting cells. Consequently, in our sys-
tem, high-affinity Salmonella-specific IgAs were gener-
ated and secreted in the intestinal lumen after S. typhimu-
rium invasion of PPs. This mechanism does not explain
how IgAs are induced toward persistent commensal mi-
croorganisms, as described (Macpherson and Uhr, 2004).
Two nonmutually exclusive possibilities could be
envisaged. (1) Commensals induce the release of broad
affinity IgAs from B1 cells directly in the LP via a T-inde-
pendent mechanism (Macpherson et al., 2000). This is
consistent with the finding that IgA CSR can also take
place in the intestinal lamina propria (Fagarasan et al.,
2001; Xu et al., 2007). Because of their innate and primitive
nature, B1 cells might release immunoglobulins with low
affinity that are polyreactive. In our system, ‘‘natural’’ or
low-affinity IgAs could be induced during noninvasive
S. typhimurium vaccination but could be undetectable
by our enzyme-linked immunosorbent assay (ELISA) sys-
Figure 5. Intestinal IgAs Protect Mice against Oral Challenge
with Pathogen S. typhimurium
Kaplan-Meier survival curves of C57BL/6 mice (n = 9–13/group) left
untreated (light gray line) or fed with 109 CFUs of aroA (black line)
or aroAinvA (gray line) S. typhimurium three times on alternate days.
Six weeks after vaccination, mice received 107 CFUs of InvA+ patho-
genic S. typhimurium, and survival was monitored daily.Imtem. (2) The persistence of commensal bacteria allows the
entry in the PP, maybe via receptor-mediated endocytosis
after opsonization with low-affinity antibodies (Mantis
et al., 2002). Alternatively, DCs scattered in the FAE could
participate to commensal bacteria uptake (Rey et al.,
2004; Salazar-Gonzalez et al., 2006).
M cell invasion is just the first step of Salmonella infec-
tion because at later times, S. typhimurium is able to move
in the mucous layer and to reach and invade enterocytes
(Galan, 2001). Our data suggest that the immune system
has developed a tool to sense the presence of bacteria
that invade M cells and to prepare against their massive
entrance by secreting specific SIgAs. Consistently, we
found that mice immunized with attenuated Salmonella
in which we could detect IgA in the feces were also pro-
tected against a lethal dose of virulent S. typhimurium. In-
terestingly, although both invasive and noninvasive bacte-
ria induced equal amounts of systemic IgG responses,
these were not efficient in protecting against an oral chal-
lenge with Salmonella in the absence of secreted IgAs.
This further confirms an important role of SIgAs in the pro-
tection against oral invasive pathogens (Michetti et al.,
1992). It is important to mention that natural IgAs are
also crucial in an initial protection toward S. typhimurium
infection because mice lacking pIgR are more susceptible
to S. typhimurium (Wijburg et al., 2006). This could be
a way to contrast the initial attack by pathogens before
the initiation of a specific response. In this regard, our
finding that S. typhimurium infection upregulates the ex-
pression of pIgR by intestinal epithelial cells further
strengthens this hypothesis.
MacPherson and colleagues have shown that theMLNs
limit the spreading of commensal bacteria to mucosal
sites (Macpherson and Uhr, 2004). In their system, E. clo-
acae is transported to the MLN by DCs, but it does not
induce IgG type of responses. If the MLNs are removed,
then the bacteria are found in the spleen and this corre-
lates with the induction of a systemic Ig response. Be-
cause S. typhimurium could reach the spleen also without
cellular transport, we wondered whether the systemic IgG
response that we found after both invasive and noninva-
sive response was due to the ability of S. typhimurium to
reach the spleen because both strains were found at this
site. However, when we splenectomized the mice before
S. typhimurium administration, we found no bacteria in
other lymphoid organs than the draining MLN, and still
we found IgG responses, suggesting that, in the absence
of the spleen, the MLN can be another site for induction of
IgG responses to pathogenic bacteria. This was con-
firmed by the detection of g1 circular transcripts at this
site after infection with noninvasive Salmonella typhimu-
rium. Whether this is due to different signals delivered
by S. typhimurium or by E. cloacae to mucosal DCs or
whether this is due to the ability of S. typhimurium to reach
the MLN in the absence of cellular transport and thus be
targeted to MLN DCs remains to be established.
In conclusion, we show here that depending on the
route of Salmonella entry, systemic or mucosal responses
are initiated. Further, PPs are absolutely required for themunity 27, 975–984, December 2007 ª2007 Elsevier Inc. 981
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Salmonella-Induced Immune Responseinitiation of a specific IgA response toSalmonella, whereas
they are dispensable for a systemic response. This com-
partmentalization of the immune response could allow
the fast and specific generation of anti-Salmonella IgAs
that are required to protect the host against subsequent
challenges with the pathogen.
EXPERIMENTAL PROCEDURES
Mice and Bacterial Strains
C57BL/6 mice (6–8 weeks old) were purchased from Harlan (Udine,
Italy). BCR-HEL VDJ ki mice (line VDJ9) were generated by standard
procedures with the recombined VDJ region of the HyHEL10 antibody,
and theywere intercrossedwith transgenicmice carrying the HyHEL10
light chain (line k5) and backcrossed to C57Bl/6 for ten generations
(a kind gift of Dr. J. Cyster, University of California, San Francisco)
and were bred under specific pathogen-free conditions at Charles
River Laboratories. All experiments were performed in accordance
with the guidelines established in the Principles of Laboratory Animal
Care (directive 86/609/EEC).
The following S. typhimurium strains on SL1344 background were
provided by G. Dougan (Imperial College, London, UK): wild-type inva-
sive strain (InvA+); noninvasive strain (InvA), defective in invA gene
and therefore unable to form productive type-three secretion system
(Everest et al., 1999); metabolically defective invasive strain (aroA),
with attenuated ability to replicate in vivo in mice; and metabolically
defective noninvasive strain (aroAinvA), with both mutations (Gots
et al., 1974). Recombinant derivatives were generated expressing
red fluorescence protein [DsRed, a kind gift of Dr. B. Glick, The Univer-
sity of Chicago (Bevis and Glick, 2002)], invasin from Yersinia entero-
colitica [pInv vector, (Schulte et al., 1998)], or inactive HEL, under tran-
scriptional control of the promoter of LacZ gene. So that HEL protein
on the surface of S. typhimurium could be exposed, a HEL-encoding
gene was cloned in frame with the one encoding for OprI protein
from P. aeruginosa [pVUB4 vector provided by P. Cornelis, Flanders
Institute for Biotechnology, Brussels, Belgium (Cornelis et al., 1996)].
Consistent with other reports (Cote-Sierra et al., 1998), we also de-
tected degraded products after overexpression of the OprI-HEL fusion
proteins (Figure S2). Bacterial strains were grown at 37C in Luria broth
supplemented with appropriate antibiotics to preserve carried muta-
tions and plasmids. Protein expression was induced by the addition
of 0.1–1 mmol/L isopropyl-L-thio-B-D-galactopyranoside (IPTG).
In Vivo Infections
For short-term experiments, mice were fed once with 107 CFUs of
InvA+ or 108 CFUs of InvA S. typhimurium in 200 ml 5% sodium bicar-
bonate. For long-term experiments, mice were fed three times on alter-
nate days with 109 CFUs of aroA or aroAinvA S. typhimurium in 200 ml
5% sodium bicarbonate. For lethal dose challenges, mice were fed
with 107 CFUs of InvA+ S. typhimurium. Serial dilutions of bacteria
preparations were plated onto Terrific Broth (TB)-agar plates so that
administered doses could be assessed.
In Vitro Infections
PPs, MLNs, and SPs were collected from naive BCR-HEL VDJ ki mice
and processed so that a single-cell suspension could be obtained. One
million cells were incubated with HEL-surface-expressing bacteria or
the same strains that did not express HEL for 4 hr in B cell medium
(Phan et al., 2003) without antibiotics and were then washed and incu-
bated in complete medium supplemented with 100 mg/ml gentamicin
for 7 days. The percentage of IgM- or IgA-expressing B cells in PPs
was evaluated through cytometry. Total cells before and 7 days after
infections were stained with PE-conjugated anti-CD19 (PharMingen)
and FITC-conjugated anti-IgM (PharMingen) or anti-IgA (Serotec).982 Immunity 27, 975–984, December 2007 ª2007 Elsevier IncEvaluation of Antigen-Specific Antibody Secretion
In Vivo and In Vitro
Serum and fecal samples were obtained from nonvaccinated and vac-
cinated mice. In brief, blood samples were incubated 1 hr at 37C, and
serum was separated by centrifugation. Fecal pellets were weighted
and dissolved in phosphate-buffered saline (PBS) 0.1 mg/ml soybean
trypsin inhibitor (1ml/100mg feces); debris were eliminated by centrifu-
gation (13000 g, 10’). Serum and fecal samples were then tested for
the presence of Salmonella-specific antibodies. Supernatants from
in vitro-infected cultures were tested for the presence of HEL-specific
antibodies. Inbrief, ELISAplateswere coatedwith lysatesof 106CFU/ml
of S. typhimurium (obtained by repeated cycles of freezing and thaw-
ing) or with 10 mg/ml HEL. After the plates were blocked, samples were
applied and bound antibodies were detected with horseradish perox-
idase (HRP)-conjugated anti-mouse IgA or anti-mouse IgG (Caltag
laboratories), thus providing also the characterization of Ig isotype.
Evaluation of Bacteria Survival and Colonization Capabilities
Total fecal samples from single mice infected with DsRed-expressing
aroA or aroAinvA S. typhimuriumwere collected every 2 hr for 6 hr after
infection, weighted, and dissolved in sterile PBS. Serial dilutions of the
suspension were plated onto TB-agar plates supplemented with IPTG.
PPs, MLNs, and SPs frommice infected with InvA+ or InvA S. typhi-
murium (day 6) were collected and processed. A fixed number of cells
was lysed with 0.5% sodium deoxycholate and plated onto TB-agar
plates.
Evaluation of Immune-System Activation
For evaluation of dendritic cell and B cell activation, PPs, MLNs, and
SPs were collected, processed, and stained with combinations of
the following antibodies (PharMingen): CD11c or CD19 (both APC con-
jugated) and H2-Kb, CD86, IA/IE or CD40 (all PE conjugated). For eval-
uation of IL-1b production, organs were disrupted in PBS 0.5% Triton-
X and analyzed through ELISA (R&D systems).
ELIspot Assay
Ninety-six-well enzyme-linked immunospot (ELIspot) plates (What-
man) were coated overnight at 4C with lysates of 4 3 106 CFU/ml
of S. typhimurium, washed, and blocked with PBS 2% bovine serum
albumin (BSA) for 1 hr at 37C. Total cells from PPs were added in
duplicates at two different cell densities (106 and 105) in Roswell
Park Memorial Institute (RPMI) medium supplemented with 2% BSA
and 2.5% fetal calf serum (FCS) and incubated 18 hr in humidified at-
mosphere at 37C and 5%CO2. After extensive washing with PBS and
PBS-Tween 20, plates were incubated 4 hr with HRP-conjugated
anti-mouse IgA (Caltag laboratories) and washed again. 3-amino, 9
ethyl-carbazole (AEC) (BD ELISPOT) was used as a substrate for per-
oxidase, and colored spots were counted with a stereomicroscope.
Immunohistochemistry
PPs were embedded in optimum cutting temperature (OCT) com-
pound (Sakura) and snap frozen. Sections 7 mm in thickness were
prepared and air dried. After endogenous peroxidases were blocked,
sections were incubated with anti-mouse IgA (Open Biosystem) or
Salmonella sp. antiserum (Virostat), both rabbit. Sections were then
incubated with anti-rabbit HRP conjugated (DAKO) and developed
with diaminobenzidine (DAB) (DakoCytomation EnVision System).
Finally, sections were counterstained with hematoxillin and mounted
with Eukitt.
Statistical Analysis
Statistical significance was evaluated by nonparametric Mann-Whit-
ney U test (Wilcoxon-Kruskal Wallis) for the analysis of variables that
were not normally distributed. Significance was defined at p < 0.05
(two-tailed test). Kaplan-Meier plots and long-rank tests were used
so that the survival differences of vaccinated mice after virulent
S. typhimurium infection could be assessed. Statistic calculations
were performed by JMP 5.1 software (SAS [Cary, NC])..
Immunity
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Experimental Procedures and four figures are available at http://www.
immunity.com/cgi/content/full/27/6/975/DC1/.
ACKNOWLEDGMENTS
This work was supported by grants from the Crohn’s and Colitis Foun-
dation of America (CCFA), Italian Association for Cancer Research
(AIRC), and Italian Ministry of Health (Ricerca Finalizzata).
Received: June 22, 2007
Revised: October 12, 2007
Accepted: October 30, 2007
Published online: December 13, 2007
REFERENCES
Baumler, A.J., Tsolis, R.M., Valentine, P.J., Ficht, T.A., and Heffron, F.
(1997). Synergistic effect of mutations in invA and lpfC on the ability of
Salmonella typhimurium to cause murine typhoid. Infect. Immun. 65,
2254–2259.
Bergqvist, P., Gardby, E., Stensson, A., Bemark, M., and Lycke, N.Y.
(2006). Gut IgA class switch recombination in the absence of CD40
does not occur in the lamina propria and is independent of germinal
centers. J. Immunol. 177, 7772–7783.
Bevis, B.J., andGlick, B.S. (2002). Rapidly maturing variants of the Dis-
cosoma red fluorescent protein (DsRed). Nat. Biotechnol. 20, 83–87.
Brandtzaeg, P. (2003). Role of secretory antibodies in the defence
against infections. Int. J. Med. Microbiol. 293, 3–15.
Cebra, J.J., and Shroff, K.E. (1994). Handbook of Mucosal Immunol-
ogy (San Diego, California: Academic Press).
Cebra, J.J., Logan, A.C., and Weinstein, P.D. (1991). The preference
for switching to expression of the IgA isotype of antibody exhibited
by B lymphocytes in Peyer’s patches is likely due to intrinsic properties
of their microenvironment. Immunol. Res. 10, 393–395.
Chieppa, M., Rescigno, M., Huang, A.Y., and Germain, R.N. (2006).
Dynamic imaging of dendritic cell extension into the small bowel lumen
in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841–
2852.
Cornelis, P., Sierra, J.C., Lim, A., Jr., Malur, A., Tungpradabkul, S.,
Tazka, H., Leitao, A., Martins, C.V., di Perna, C., Brys, L., et al.
(1996). Development of new cloning vectors for the production of
immunogenic outer membrane fusion proteins in Escherichia coli.
Biotechnology (N. Y.) 14, 203–208.
Cote-Sierra, J., Jongert, E., Bredan, A., Gautam, D.C., Parkhouse, M.,
Cornelis, P., De Baetselier, P., and Revets, H. (1998). A new mem-
brane-bound OprI lipoprotein expression vector. High production of
heterologous fusion proteins in gram (-) bacteria and the implications
for oral vaccination. Gene 221, 25–34.
DeRosier, D.J. (1998). The turn of the screw: The bacterial flagellar mo-
tor. Cell 93, 17–20.
Everest, P., Ketley, J., Hardy, S., Douce, G., Khan, S., Shea, J., Holden,
D., Maskell, D., and Dougan, G. (1999). Evaluation of Salmonella
typhimuriummutants in amodel of experimental gastroenteritis. Infect.
Immun. 67, 2815–2821.
Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., and Honjo, T.
(2001). In situ class switching and differentiation to IgA-producing cells
in the gut lamina propria. Nature 413, 639–643.
Galan, J.E. (2001). Salmonella interactions with host cells: Type III se-
cretion at work. Annu. Rev. Cell Dev. Biol. 17, 53–86.
Gots, R.E., Formal, S.B., and Giannella, R.A. (1974). Indomethacin
inhibition of Salmonella typhimurium, Shigella flexneri, and cholera-
mediated rabbit ileal secretion. J. Infect. Dis. 130, 280–284.
Grutzkau, A., Hanski, C., Hahn, H., and Riecken, E.O. (1990). Involve-
ment of M cells in the bacterial invasion of Peyer’s patches: A commonImmechanism shared by Yersinia enterocolitica and other enteroinvasive
bacteria. Gut 31, 1011–1015.
Hayakawa, K., and Hardy, R.R. (1988). Normal, autoimmune, and
malignant CD5+ B cells: The Ly-1 B lineage? Annu. Rev. Immunol. 6,
197–218.
Isberg, R.R., and Leong, J.M. (1990). Multiple beta 1 chain integrins are
receptors for invasin, a protein that promotes bacterial penetration into
mammalian cells. Cell 60, 861–871.
Jones, B.D., Ghori, N., and Falkow, S. (1994). Salmonella typhimurium
initiates murine infection by penetrating and destroying the specialized
epithelial M cells of the Peyer’s patches. J. Exp. Med. 180, 15–23.
Kraehenbuhl, J.P., and Neutra, M.R. (1992). Molecular and cellular ba-
sis of immune protection of mucosal surfaces. Physiol. Rev. 72, 853–
879.
Litinskiy, M.B., Nardelli, B., Hilbert, D.M., He, B., Schaffer, A., Casali,
P., and Cerutti, A. (2002). DCs induce CD40-independent immuno-
globulin class switching through BLyS and APRIL. Nat. Immunol. 3,
822–829.
Macpherson, A.J., and Harris, N.L. (2004). Interactions between com-
mensal intestinal bacteria and the immune system. Nat. Rev. Immunol.
4, 478–485.
Macpherson, A.J., and Uhr, T. (2004). Induction of protective IgA by
intestinal dendritic cells carrying commensal bacteria. Science 303,
1662–1665.
Macpherson, A.J., Gatto, D., Sainsbury, E., Harriman, G.R., Hengart-
ner, H., and Zinkernagel, R.M. (2000). A primitive T cell-independent
mechanism of intestinal mucosal IgA responses to commensal bacte-
ria. Science 288, 2222–2226.
Mantis, N.J., Cheung, M.C., Chintalacharuvu, K.R., Rey, J., Corthesy,
B., and Neutra, M.R. (2002). Selective adherence of IgA to murine
Peyer’s patch M cells: Evidence for a novel IgA receptor. J. Immunol.
169, 1844–1851.
Marchetti, M., Sirard, J.C., Sansonetti, P., Pringault, E., and Kerneis, S.
(2004). Interaction of pathogenic bacteria with rabbit appendix M cells:
Bacterial motility is a key feature in vivo. Microbes Infect. 6, 521–528.
Mastroeni, P., and Sheppard, M. (2004). Salmonella infections in the
mouse model: Host resistance factors and in vivo dynamics of bacte-
rial spread and distribution in the tissues. Microbes Infect. 6, 398–405.
Mastroeni, P., Simmons, C., Fowler, R., Hormaeche, C.E., and Dou-
gan, G. (2000). Igh-6(/) (B-cell-deficient) mice fail to mount solid
acquired resistance to oral challenge with virulent Salmonella enterica
serovar typhimurium and show impaired Th1 T-cell responses to
Salmonella antigens. Infect. Immun. 68, 46–53.
Mestecky, J., and McGhee, J.R. (1987). Immunoglobulin A (IgA):
Molecular and cellular interactions involved in IgA biosynthesis and
immune response. Adv. Immunol. 40, 153–245.
Michetti, P., Mahan, M.J., Slauch, J.M., Mekalanos, J.J., and Neutra,
M.R. (1992). Monoclonal secretory immunoglobulin A protects mice
against oral challenge with the invasive pathogen Salmonella typhimu-
rium. Infect. Immun. 60, 1786–1792.
Mora, J.R., Iwata, M., Eksteen, B., Song, S.Y., Junt, T., Senman, B.,
Otipoby, K.L., Yokota, A., Takeuchi, H., Ricciardi-Castagnoli, P.,
et al. (2006). Generation of gut-homing IgA-secreting B cells by intes-
tinal dendritic cells. Science 314, 1157–1160.
Mostov, K.E. (1994). Transepithelial transport of immunoglobulins.
Annu. Rev. Immunol. 12, 63–84.
Neumann, B., Luz, A., Pfeffer, K., and Holzmann, B. (1996). Defective
Peyer’s patch organogenesis in mice lacking the 55-kD receptor for
tumor necrosis factor. J. Exp. Med. 184, 259–264.
Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick,
B.A., Vyas, J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. (2005).
CX3CR1-mediated dendritic cell access to the intestinal lumen and
bacterial clearance. Science 307, 254–258.munity 27, 975–984, December 2007 ª2007 Elsevier Inc. 983
Immunity
Salmonella-Induced Immune ResponsePenheiter, K.L., Mathur, N., Giles, D., Fahlen, T., and Jones, B.D.
(1997). Non-invasive Salmonella typhimurium mutants are avirulent
because of an inability to enter and destroy M cells of ileal Peyer’s
patches. Mol. Microbiol. 24, 697–709.
Phan, T.G., Amesbury, M., Gardam, S., Crosbie, J., Hasbold, J., Hodg-
kin, P.D., Basten, A., and Brink, R. (2003). B cell receptor-independent
stimuli trigger immunoglobulin (Ig) class switch recombination and
production of IgG autoantibodies by anergic self-reactive B cells.
J. Exp. Med. 197, 845–860.
Rescigno, M., Rotta, G., Valzasina, B., and Ricciardi-Castagnoli, P.
(2001a). Dendritic cells shuttle microbes across gut epithelial mono-
layers. Immunobiology 204, 572–581.
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bo-
nasio, R., Granucci, F., Kraehenbuhl, J.P., and Ricciardi-Castagnoli, P.
(2001b). Dendritic cells express tight junction proteins and penetrate
gut epithelial monolayers to sample bacteria. Nat. Immunol. 2, 361–
367.
Rey, J., Garin, N., Spertini, F., and Corthesy, B. (2004). Targeting of
secretory IgA to Peyer’s patch dendritic and T cells after transport
by intestinal M cells. J. Immunol. 172, 3026–3033.
Salazar-Gonzalez, R.M., Niess, J.H., Zammit, D.J., Ravindran, R.,
Srinivasan, A., Maxwell, J.R., Stoklasek, T., Yadav, R., Williams, I.R.,
Gu, X., et al. (2006). CCR6-mediated dendritic cell activation of patho-
gen-specific T cells in Peyer’s patches. Immunity 24, 623–632.984 Immunity 27, 975–984, December 2007 ª2007 Elsevier IncSato, A., Hashiguchi, M., Toda, E., Iwasaki, A., Hachimura, S., and
Kaminogawa, S. (2003). CD11b+ Peyer’s patch dendritic cells secrete
IL-6 and induce IgA secretion from naive B cells. J. Immunol. 171,
3684–3690.
Schulte, R., Zumbihl, R., Kampik, D., Fauconnier, A., and Autenrieth,
I.B. (1998). Wortmannin blocks Yersinia invasin-triggered internaliza-
tion, but not interleukin-8 production by epithelial cells. Med. Micro-
biol. Immunol. (Berl.) 187, 53–60.
Vajdy, M., Kosco-Vilbois, M.H., Kopf, M., Kohler, G., and Lycke, N.
(1995). Impaired mucosal immune responses in interleukin 4-targeted
mice. J. Exp. Med. 181, 41–53.
Vazquez-Torres, A., Jones-Carson, J., Baumler, A.J., Falkow, S., Val-
divia, R., Brown, W., Le, M., Berggren, R., Parks, W.T., and Fang, F.C.
(1999). Extraintestinal dissemination of Salmonella by CD18-express-
ing phagocytes. Nature 401, 804–808.
Wijburg, O.L., Uren, T.K., Simpfendorfer, K., Johansen, F.E., Brandt-
zaeg, P., and Strugnell, R.A. (2006). Innate secretory antibodies pro-
tect against natural Salmonella typhimurium infection. J. Exp. Med.
203, 21–26.
Xu, W., He, B., Chiu, A., Chadburn, A., Shan, M., Buldys, M., Ding, A.,
Knowles, D.M., Santini, P.A., and Cerutti, A. (2007). Epithelial cells
trigger frontline immunoglobulin class switching through a pathway
regulated by the inhibitor SLPI. Nat. Immunol. 8, 294–303..
